Subsequently, TUG1 was pervasively studied in multiple cancers, such as osteosarcoma [28], bladder cancer [29], non-small-cell lung carcinoma [30], colorectal cancer [31], and esophageal squamous cell carcinoma [32]. Here, TUG1 is linked to urinary bladder carcinoma.